Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models
Lantern Pharma Inc.
Lantern Pharma Inc. (LTRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 90,600 | $286,296 | +3% | 0% |
| 2. | Voss Capital Travis Cocke | 50,000 | $158,000 | 0.01% | |
| 3. | Horizon Asset Management Murray Stahl | 27,582 | $87,159 | -5% | 0% |
| 4. | 16,400 | $51,824 | -5% | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 10,000 | $150,000.00 | 10,000 | 2020-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.09 | 4,354 | $13,453.86 | 114,272 | 2025-06-13 | Filing | |
| $3.09 | 14,218 | $43,933.62 | 373,178 | 2025-06-13 | Filing | |
| $3.09 | 1,903 | $5,880.27 | 49,957 | 2025-06-13 | Filing | |
| $3.09 | 12,319 | $38,065.71 | 323,335 | 2025-06-13 | Filing | |
| $3.09 | 7,206 | $22,266.54 | 189,117 | 2025-06-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,075,952 | $3,400,008 | 4.68% | |
| 2. | 363,720 | $1,149,355 | 0% | |
| 3. | 200,000 | $632,000 | 0.58% | |
| 4. | 91,891 | $290,438 | 0% | |
| 5. | 56,507 | $178,561 | 0% |
News See All
Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to our First Quarter 2025 Earnings Call. As a reminder, this call is being recorded, and all attendees are in a listen-only mode.
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to our Fourth Quarter and Year End 2024 Earnings Call. As a reminder, this call is being recorded, and all attendees are in a listen-only mode.
10 AI News and Ratings You Should Not Miss
On February 19, CNBC reported significant funding rounds for multiple AI-focused startups, highlighting the quick expansion of AI innovations across industries like healthcare, cloud computing, and model...
Top 10 AI Stocks Dominating Wall Street
The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.
Complete List of All AI Companies Under $2 Billion Market Cap
It's clear that AI holds immense promise but it comes with significant risks.
10 AI News That Broke The Internet
Should original content contributors be paid every time large language models use their work? OpenAI CEO Sam Altman believes they should, much like Name, Image, and Likeness (NIL) deals for college athletes...
15 AI News Updates That Broke The Internet
With Trump taking in the reigns soon, steps toward overhauling the US policy have begun.
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to our Third Quarter 2024 earnings call. As a reminder, this call is being recorded, and all attendees are in a listen-only mode.
11 Penny Stocks That Will Make You A Millionaire
Penny stocks are often overlooked by most investors.
Billionaire Hedge Funds
